首页 | 本学科首页   官方微博 | 高级检索  
     

免疫抑制剂对移植术后血脂异常的研究
引用本文:应亮,邱丰. 免疫抑制剂对移植术后血脂异常的研究[J]. 中国医药导报, 2012, 0(31): 39-41
作者姓名:应亮  邱丰
作者单位:上海交通大学医学院附属仁济医院泌尿外科,上海200127
摘    要:
心脑血管合并症是导致长期存活器官移植患者移植器官功能死亡的主要原因之一。在导致心脑动脉硬化的诸多因素中,高脂血症是其中最重要的原因。文章详细地论述了不同免疫抑制剂对血脂的影响,包括皮质类固醇激素、环孢霉素、他克莫司、西罗莫司、吗替麦考酚酯、硫唑嘌呤等,最终发现吗替麦考酚酯是对血脂影响最小的药物之一。

关 键 词:免疫抑制剂  器官移植  血脂异常

Research of immunosuppressant on dyslipidemia after organ transplantation
YING Liang,QIU Feng. Research of immunosuppressant on dyslipidemia after organ transplantation[J]. China Medical Herald, 2012, 0(31): 39-41
Authors:YING Liang  QIU Feng
Affiliation:Department of Urology,Renji Hospital Affiliated to School of Medicine,Shanghai Jiaotong University,Shanghai 200127,China
Abstract:
Cardiovascular and cerebrovascular complications is one of the major causes of transplanted organ death for the long-term survival patients with organ transplantation.In many factors of the resulting cardiac cerebral arteriosclerosis,hyperlipidemia is one of the most important reasons.The immunosuppressive effects on serum lipids were reviewed in detail in this paper,including Corticosteroids,Cyclosporine,Tacrolimus,Sirolimus,Mycophenolate Mofetil,Azathioprine,and ultimately Mycophenolate Mofetil is one of the drugs which has minimal impact on blood lipids.
Keywords:Immunosuppressant  Organ transplantation  Dyslipidemia
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号